How to Make Mounjaro Drink for Weight Loss: A Comprehensive Guide

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in Mounjaro, works by mimicking two natural hormones that control hunger and glucose metabolism. PlexusDx delivers personalized tirzepatide injection therapy from licensed 503A compounding pharmacies, making precision weight loss accessible across all 50 states without insurance requirements.

How Tirzepatide Injection Works for Weight Loss

Tirzepatide targets two hormone pathways in your body: GLP-1 and GIP receptors. These receptors signal your brain to reduce hunger, slow stomach emptying, and improve how your body handles blood sugar. Clinical trials show participants using tirzepatide lost 20-22% of their starting body weight over 68 weeks, significantly more than diet and exercise alone.

The medication works best when combined with sustainable eating habits and physical activity. Your body gradually responds to tirzepatide as your dose increases, allowing your appetite suppression to build naturally. This dual-pathway approach makes tirzepatide effective for people whose bodies respond differently to single-hormone treatments.

Tirzepatide Dosing Schedule and Injection Instructions

Tirzepatide is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. Treatment begins at a low dose and increases gradually every four weeks until reaching your therapeutic dose. This gradual escalation minimizes nausea and allows your body to adjust to the medication's appetite-suppressing effects.

PlexusDx provides detailed injection training and support materials to ensure you feel confident self-administering your weekly doses. Your dose may need to go up based on your weight loss progress and tolerance, but your price stays the same at $249 per month. Most patients reach their optimal dose within 16-20 weeks of starting therapy.

Understanding Tirzepatide's Dual Mechanism of Action

Unlike single-hormone GLP-1 therapies, tirzepatide activates both GLP-1 and GIP receptors simultaneously. GLP-1 reduces appetite and increases insulin secretion, while GIP enhances these effects and improves fat metabolism. This combination creates a more powerful weight loss signal than GLP-1 alone, which explains why tirzepatide users typically lose more weight in the same timeframe.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Tirzepatide: Accessibility and Personalization

PlexusDx compounded tirzepatide injection begins at $289/mo (or $249/mo on the 6-month plan) across all commitment tiers, with no insurance required and HSA/FSA eligibility. The medication is prepared by licensed 503A compounding pharmacies and shipped directly to your home in all 50 states. Membership fees and hidden costs do not apply—you pay one flat price regardless of your dose level.

PlexusDx combines tirzepatide therapy with optional genetic testing through the Precision Peptide Genetic Test ($99 add-on after your first month). This test identifies your FTO, MC4R, GLP1R, and GIPR variants, mapping how your unique genetics influence weight regulation and peptide therapy response. Personalized treatment based on your genetic profile increases the likelihood of achieving sustainable weight loss results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded tirzepatide from PlexusDx the same as brand-name Mounjaro?

Compounded tirzepatide contains the identical active ingredient as Mounjaro but is prepared by licensed 503A compounding pharmacies rather than manufactured by a pharmaceutical company. Both deliver the same dual GLP-1/GIP mechanism, though PlexusDx offers significantly lower cost ($289/month vs. $900+) and broader state availability.

How much weight loss can I expect with tirzepatide injection?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Does PlexusDx require insurance or membership fees for tirzepatide?

No. PlexusDx tirzepatide injection costs $289 per month flat with no insurance required, no membership fees, and no per-dose charges. HSA and FSA funds are accepted, making it accessible to most patients regardless of insurance status across all 50 states.

What are the most common side effects of tirzepatide injection?

Nausea is the most frequently reported side effect, especially during dose escalation, typically subsiding within 2-4 weeks as your body adjusts. Less common effects include vomiting, diarrhea, constipation, and fatigue. Serious side effects are rare but can include pancreatitis; discontinue immediately and contact your healthcare provider if severe abdominal pain develops.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence tirzepatide response and weight-loss potential. Mapping 14 pathways and 150+ genetic insights helps PlexusDx recommend whether tirzepatide or semaglutide may be more effective for your unique metabolic profile.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.